Skip to main content

Table 2 Estimated prevalence rates for different pathogens sorted by inclusion group

From: Prevalence of selected infectious agents in Swedish cats with fever and/or anemia compared to cats without fever and/or anemia and to stable/stray cats

Summary of test results

Positive test results n

prevalence % and [confidence interval %]

Group

AF

CC

SS

Total

Total numbers of samples

42

34

16

92

Bartonella spp. IgG

13

17

10

40

31 [19–46]

50 [34–66]

63 [39–82]

43 [34–54]

Bartonella spp. PCR

0

0

1

1

0 [0.0-8.4]

0 [0.0–10]

6.2 [1.1–28]

1.1 [0.19–5.9]

Anaplasma/Ehrlichia species

0

0

0

0

0 [0.0-8.4]

0 [0.0–10]

0 [0.0–19]

0 [0.0–4.0]

Feline foamy virus antibodies

21

11

10

41

50 [36–65]

32 [19–49]

63 [39–82]

45 [35–55]

Feline immunodeficiency virus antibodies

0

1

2

3

0 [0.0-8.4]

2.9 [0.52-15]

13 [3.5–36]

3.3 [1.1–9.2]

Feline leukemia virus antigen

1

0

0

1

2.4 [0.42-12]

0 [0.0–10]

0 [0.0–19]

1.1 [0.19–5.9]

Felis catus gammaherpesvirus-1 antibodies

25

25

12

62

60 [45–73]

74 [57–85]

75 [51–90]

67 [57–76]

Haemotropic Mycoplasma PCR

2

3

2

7

4.8 [1.3–16]

8.8 [3.0–23]

13 [3.5–36]

7.6 [3.7–15]

Toxoplasma gondii antibodies

15

8

11

34

36 [23–51]

24 [12–40]

69 [44–86]

37 [28–47]

  1. AF anemia/fever group, CC control cat group, SS stray/stable group
  2. (% positive) [95% Confidence interval]
  3. Prevalence is described as percentage of positive test results, out of tested samples in each category, and 95% confidence interval, as a range of percent